These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 26104054)

  • 1. Evaluating Vitamin D Repletion Regimens and Effects in Veteran Patients.
    Aterrado S; Ono G; Kanehira-Mar S; Meier J; Swislocki A
    Ann Pharmacother; 2015 Sep; 49(9):969-77. PubMed ID: 26104054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial.
    Wetmore JB; Kimber C; Mahnken JD; Stubbs JR
    Br J Nutr; 2016 Dec; 116(12):2074-2081. PubMed ID: 28065190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calculated free and bioavailable vitamin D metabolite concentrations in vitamin D-deficient hip fracture patients after supplementation with cholecalciferol and ergocalciferol.
    Glendenning P; Chew GT; Inderjeeth CA; Taranto M; Fraser WD
    Bone; 2013 Oct; 56(2):271-5. PubMed ID: 23792937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of vitamin D deficiency within a large integrated health care delivery system.
    Stratton-Loeffler MJ; Lo JC; Hui RL; Coates A; Minkoff JR; Budayr A
    J Manag Care Pharm; 2012 Sep; 18(7):497-505. PubMed ID: 22971203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a 10-day course of a high dose calciferol versus a single mega dose of ergocalciferol in correcting vitamin D deficiency.
    Melhem SJ; Aiedeh KM; Hadidi KA
    Ann Saudi Med; 2015; 35(1):13-8. PubMed ID: 26142932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in outcomes between cholecalciferol and ergocalciferol supplementation in veterans with inflammatory bowel disease.
    Youssef D; Bailey B; Atia A; El-Abbassi A; Manning T; Peiris AN
    Geriatr Gerontol Int; 2012 Jul; 12(3):475-80. PubMed ID: 22233182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ergocalciferol versus Cholecalciferol for Nutritional Vitamin D Replacement in CKD.
    Mangoo-Karim R; Da Silva Abreu J; Yanev GP; Perez NN; Stubbs JR; Wetmore JB
    Nephron; 2015; 130(2):99-104. PubMed ID: 26044704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity in serum 25-hydroxy-vitamin D response to cholecalciferol in elderly women with secondary hyperparathyroidism and vitamin D deficiency.
    Giusti A; Barone A; Pioli G; Girasole G; Razzano M; Pizzonia M; Pedrazzoni M; Palummeri E; Bianchi G
    J Am Geriatr Soc; 2010 Aug; 58(8):1489-95. PubMed ID: 20646099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription ergocalciferol dosing for vitamin D repletion: a retrospective evaluation.
    Vande Griend JP; McQueen RB; Linnebur SA; Vondracek SF
    Pharmacotherapy; 2012 Feb; 32(2):135-41. PubMed ID: 22392422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot Study Evaluating Efficacy of 2 Regimens for Hypovitaminosis D Repletion in Pediatric Inflammatory Bowel Disease.
    Simek RZ; Prince J; Syed S; Sauer CG; Martineau B; Hofmekler T; Freeman AJ; Kumar A; McElhanon BO; Schoen BT; Tenjarla G; McCracken C; Ziegler TR; Tangpricha V; Kugathasan S
    J Pediatr Gastroenterol Nutr; 2016 Feb; 62(2):252-8. PubMed ID: 26196201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of High vs. Conventional Ergocalciferol Dose for Increasing 25-Hydroxyvitamin D and Suppressing Parathyroid Hormone Levels in Stage III-IV CKD with Vitamin D Deficiency/Insufficiency: A Randomized Controlled Trial.
    Thimachai P; Supasyndh O; Chaiprasert A; Satirapoj B
    J Med Assoc Thai; 2015 Jul; 98(7):643-8. PubMed ID: 26267985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency.
    Leventis P; Kiely PD
    Scand J Rheumatol; 2009; 38(2):149-53. PubMed ID: 18991184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly.
    Romagnoli E; Mascia ML; Cipriani C; Fassino V; Mazzei F; D'Erasmo E; Carnevale V; Scillitani A; Minisola S
    J Clin Endocrinol Metab; 2008 Aug; 93(8):3015-20. PubMed ID: 18492750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis.
    Hiremath GS; Cettomai D; Baynes M; Ratchford JN; Newsome S; Harrison D; Kerr D; Greenberg BM; Calabresi PA
    Mult Scler; 2009 Jun; 15(6):735-40. PubMed ID: 19383644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D2 versus vitamin D3 supplementation in hemodialysis patients: a comparative pilot study.
    Daroux M; Shenouda M; Bacri JL; Lemaitre V; Vanhille P; Bataille P
    J Nephrol; 2013; 26(1):152-7. PubMed ID: 22641581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response effect of ergocalciferol therapy on serum 25-hydroxyvitamin D concentration during critical illness.
    Dickerson RN; Berry SC; Ziebarth JD; Swanson JM; Maish GO; Minard G; Brown RO
    Nutrition; 2015 Oct; 31(10):1219-23. PubMed ID: 26213135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and prevention of vitamin D insufficiency in cystic fibrosis patients: comparative efficacy of ergocalciferol, cholecalciferol, and UV light.
    Khazai NB; Judd SE; Jeng L; Wolfenden LL; Stecenko A; Ziegler TR; Tangpricha V
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2037-43. PubMed ID: 19336509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin-D2 treatment-associated decrease in 25(OH)D3 level is a reciprocal phenomenon: a randomized controlled trial.
    Hammami MM; Abuhdeeb K; Hammami S; Yusuf A
    BMC Endocr Disord; 2019 Jan; 19(1):8. PubMed ID: 30658603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial of vitamin D replacement strategies in pediatric CF patients.
    Simoneau T; Sawicki GS; Milliren CE; Feldman HA; Gordon CM
    J Cyst Fibros; 2016 Mar; 15(2):234-41. PubMed ID: 26211605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case report: Three patients with substantial serum levels of 3-epi-25(OH)D including one with 3-epi-25(OH)D2 while on high-dose ergocalciferol.
    Wiebe D; Binkley N
    J Clin Endocrinol Metab; 2014 Apr; 99(4):1117-21. PubMed ID: 24476080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.